Page last updated: 2024-11-05

vigabatrin and Atrophy

vigabatrin has been researched along with Atrophy in 5 studies

Atrophy: Decrease in the size of a cell, tissue, organ, or multiple organs, associated with a variety of pathological conditions such as abnormal cellular changes, ischemia, malnutrition, or hormonal changes.

Research Excerpts

ExcerptRelevanceReference
"To describe the clinical pattern of retinal atrophy in children caused by the anticonvulsant vigabatrin."7.72Characteristic retinal atrophy with secondary "inverse" optic atrophy identifies vigabatrin toxicity in children. ( Buncic, JR; Logan, WJ; MacKeen, LD; Munn, JR; Panton, CM; Westall, CA, 2004)
"To describe the clinical pattern of retinal atrophy in children caused by the anticonvulsant vigabatrin."3.72Characteristic retinal atrophy with secondary "inverse" optic atrophy identifies vigabatrin toxicity in children. ( Buncic, JR; Logan, WJ; MacKeen, LD; Munn, JR; Panton, CM; Westall, CA, 2004)
"Seizures in a term infant with Ohtahara syndrome, associated with polymicrogyria, and a pre-term neonate with similar clinical features, failed to respond to conventional anticonvulsants, but were controlled with vigabatrin monotherapy."3.69Vigabatrin monotherapy in resistant neonatal seizures. ( Barwick, DD; Baxter, PS; Gardner-Medwin, D; Ince, P; Livingston, J; Murdoch-Eaton, D, 1995)
"EEG showed typical hypsarrhythmia in 8 cases, asymmetrical hypsarrhythmia in 1 case and modified hypsarrhythmia in another case."1.30[West's syndrome in patients with cerebral paralysis and periventricular leukomalacia: a good response to treatment]. ( Caraballo, R; Cersósimo, R; Fejerman, N; Intruvini, S; Pociecha, J, 1997)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (40.00)18.2507
2000's3 (60.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kölker, S1
Hoffmann, GF1
Schor, DS1
Feyh, P1
Wagner, L1
Jeffrey, I1
Pourfarzam, M1
Okun, JG1
Zschocke, J1
Baric, I1
Bain, MD1
Jakobs, C1
Chalmers, RA1
Buncic, JR1
Westall, CA1
Panton, CM1
Munn, JR1
MacKeen, LD1
Logan, WJ1
Rebolleda, G1
García Pérez, JL1
Muñoz Negrete, FJ1
Tang, RA1
Baxter, PS1
Gardner-Medwin, D1
Barwick, DD1
Ince, P1
Livingston, J1
Murdoch-Eaton, D1
Caraballo, R1
Cersósimo, R1
Intruvini, S1
Pociecha, J1
Fejerman, N1

Other Studies

5 other studies available for vigabatrin and Atrophy

ArticleYear
Glutaryl-CoA dehydrogenase deficiency: region-specific analysis of organic acids and acylcarnitines in post mortem brain predicts vulnerability of the putamen.
    Neuropediatrics, 2003, Volume: 34, Issue:5

    Topics: Acidosis; Acute Disease; Adolescent; Anticonvulsants; Atrophy; Brain; Carnitine; DNA Mutational Anal

2003
Characteristic retinal atrophy with secondary "inverse" optic atrophy identifies vigabatrin toxicity in children.
    Ophthalmology, 2004, Volume: 111, Issue:10

    Topics: Adolescent; Anticonvulsants; Atrophy; Child; Electroretinography; Female; Humans; Infant; Male; Opti

2004
Vigabatrin toxicity in children.
    Ophthalmology, 2005, Volume: 112, Issue:7

    Topics: Anticonvulsants; Atrophy; Child; Diagnostic Techniques, Ophthalmological; Humans; Optic Atrophy; Ret

2005
Vigabatrin monotherapy in resistant neonatal seizures.
    Seizure, 1995, Volume: 4, Issue:1

    Topics: Agenesis of Corpus Callosum; Anticonvulsants; Atrophy; Brain; Cerebral Cortex; Dose-Response Relatio

1995
[West's syndrome in patients with cerebral paralysis and periventricular leukomalacia: a good response to treatment].
    Revista de neurologia, 1997, Volume: 25, Issue:145

    Topics: Anticonvulsants; Atrophy; Cerebral Palsy; Cerebral Ventricles; Child; Child, Preschool; Female; gamm

1997